Quantum Biopharma (NASDAQ:QNTM) Shares Down 4.8% – Here’s Why

Quantum Biopharma Ltd. (NASDAQ:QNTM)’s stock price fell 4.8% during trading on Monday . The stock traded as low as $4.20 and last traded at $4.40. 38,219 shares changed hands during trading, a decline of 97% from the average session volume of 1,134,356 shares. The stock had previously closed at $4.62.

Quantum Biopharma Stock Performance

The firm has a market capitalization of $8.44 million, a P/E ratio of -0.29 and a beta of 0.37. The firm has a 50 day simple moving average of $5.48.

Institutional Trading of Quantum Biopharma

A hedge fund recently raised its stake in Quantum Biopharma stock. AdvisorShares Investments LLC grew its holdings in shares of Quantum Biopharma Ltd. (NASDAQ:QNTM) by 163.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 69,078 shares of the company’s stock after buying an additional 42,845 shares during the quarter. AdvisorShares Investments LLC owned 3.60% of Quantum Biopharma worth $254,000 at the end of the most recent reporting period. Institutional investors own 1.24% of the company’s stock.

Quantum Biopharma Company Profile

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.